Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells

Treatment approaches to nasopharyngeal carcinoma: a review

(2010) Francesco Caponigro et al.   ANTI-CANCER DRUGS

Metronomic administration of Zoledronic Acid and Taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial

(2010) Gaetano Facchini et al.   CANCER BIOLOGY & THERAPY

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

(2010) Kai Kessenbrock et al.   CELL

Nasopharyngeal carcinoma: The next challenges

(2010) Albiruni R.A. Razak et al.   EUROPEAN JOURNAL OF CANCER

Nasopharyngeal carcinoma: alternative treatment options after disease progression

(2010) Belisario A Arango et al.   Expert Review of Anticancer Therapy

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial

(2010) Rebecca Aft et al.   LANCET ONCOLOGY

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

(2009) Michael Gnant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Exploring the anti-tumour activity of bisphosphonates in early breast cancer

(2008) M.C. Winter et al.   CANCER TREATMENT REVIEWS

Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells

(2008) B KARABULUT et al.   CELL BIOLOGY INTERNATIONAL

Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo

(2008) P. D. Ottewell et al.   CLINICAL CANCER RESEARCH

Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line

(2008) Francesco Fabbri et al.   Journal of Translational Medicine

Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers

(2007) Ying-Ying Li et al.   LUNG CANCER